Most Recent
Sandoz entitled to generic Lexapro licence, IP Australia finds in blow to Lundbeck
Intellectual Property April 15, 2019 10:18 pm By Christine Caulfield

Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Lundbeck sues IP Australia, Sandoz to escape undertaking over Lexapro licence
Intellectual Property April 9, 2019 4:44 pm By Miklos Bolza

Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Judge ‘uncomfortable’ with common fund order in toxic foam class actions
Class Actions April 3, 2019 5:21 pm By Miklos Bolza

A judge overseeing three toxic foam class actions against the Commonwealth of Australia has said he’s not comfortable approving a common fund order which does […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Deep Investments can’t take another shot at case, Full Court says
Appeals April 1, 2019 2:28 pm By Cat Fredenburgh

The Full Court has denied a bid by Deep Investments to vary orders dismissing its case against a solicitor and six others over $10 million […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Class action trial against WorleyParsons back on as new judge steps in
Class Actions March 20, 2019 12:55 pm By Miklos Bolza

Trial in a shareholder class action against engineering company WorleyParsons will be heard by a new judge in late August, six months after it was […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Sandoz wins stay of $26.3M Lexapro judgment
Intellectual Property March 20, 2019 3:41 pm By Miklos Bolza

Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Liquidator loses appeal to block evidence as ATO aims at 10 year ban
Restructuring & Insolvency March 11, 2019 8:47 pm By Miklos Bolza

An appeals court has dismissed a challenge by Veritas Advisory principal liquidator David Iannuzzi to the admissibility of evidence submitted by the Australian Taxation Office […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
CIMIC slugged with costs after class action trial vacated
Class Actions March 7, 2019 4:32 pm By Miklos Bolza

Global engineering firm CIMIC Group has been hit with costs after a last-minute subpoena of three new potential witnesses caused the three-week trial that was […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
WorleyParsons class action trial delayed in 11th hour judge swap
Trials March 6, 2019 7:46 pm By Miklos Bolza

The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Lundbeck earned $51.7M in settlements with generic makers over Lexapro patent
Intellectual Property February 27, 2019 10:09 pm By Christine Caulfield

Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.